Recent advancements in epigenetics have highlighted the critical role of multi-protein complexes in "turning on" genes. Central to this process is the , a type of nuclear receptor that acts as a switch for gene expression in response to Vitamin A derivatives like All-Trans Retinoic Acid (ATRA) . The Key Players
Understanding this network is vital for cancer research. Disruptions in any of these three components—UTX, MLL4, or p300—can impede the maintenance of active enhancers, leading to the "silencing" of genes that normally prevent tumor growth. Resources for Further Reading 53191.rar
Based on the surrounding context of this identifier in research databases, Disruptions in any of these three components—UTX, MLL4,
For raw datasets and supplementary files, researchers often use the NASA Technical Reports Server or the WIPO Knowledge Repository for related patent information. Crucially, research shows that UTX acts as a
Understanding the UTX-MLL4-p300 Regulatory Network in Gene Activation
This binding triggers the recruitment of UTX . Crucially, research shows that UTX acts as a "bridge," bringing MLL4 and p300 to the specific DNA site.